4.4 Article

Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus

Journal

JOURNAL OF GENERAL VIROLOGY
Volume 103, Issue 6, Pages -

Publisher

MICROBIOLOGY SOC
DOI: 10.1099/jgv.0.001754

Keywords

HIV-1; CRISPR; Latency; HIV-1 reservoir; viral activation; shock and kill

Funding

  1. Gilead HIV Cure Grant Program [00408]

Ask authors/readers for more resources

CRISPR/dCas9-based activation systems have shown promise in reversing HIV-1 latency. In this study, the dCas9-VPR system was evaluated and the optimal gRNA target site in the HIV-1 5'LTR promoter was identified. The results demonstrated that the dCas9-VPR system can effectively activate HIV-1 and the optimal activation region is located -165 to -106 bp from the transcription start site.
CRISPR/dCas9-based activation systems (CRISPRa) enable sequence-specific gene activation and are therefore of particular interest for the 'shock and kill' cure approach against HIV-1 infections. This approach aims to activate the latent HIV-1 proviruses in infected cells and subsequently kill these cells. Several CRISPRa systems have been shown to specifically and effectively activate latent HIV-1 when targeted to the HIV-1 5'LTR promoter, making them a promising 'shock' strategy. Here, we aimed to evaluate the dCas9-VPR system for its applicability in reversing HIV-1 latency and identify the optimal gRNA target site in the HIV-1 5'LTR promoter leading to the strongest activation of the provirus with this system. We systematically screened the HIV-1 promoter by selecting 14 specific gRNAs that cover almost half of the HIV-1 promoter from the 3' half of the U3 until the beginning of the R region. Screening in several latently HIV-1 infected cell lines showed that dCas9-VPR leads to a high activation of HIV-1 and that gRNA-V and -VII induce the strongest activation of replication competent latent provirus. This data indicates that the optimal activation region in the HIV-1 promoter for the dCas9-VPR system is located -165 to -106 bp from the transcription start site and that it is consistent with the optimal activation region reported for other CRISPRa systems. Our data demonstrates that the dCas9-VPR system is a powerful tool for HIV-1 activation and could be harnessed for the 'shock and kill' cure approach.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available